| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99215 |
Prolong outpt/office vis |
17,471 |
16,842 |
$2.92M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
7,706 |
7,422 |
$743K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
4,637 |
4,252 |
$588K |
| 99205 |
Prolong outpt/office vis |
2,060 |
2,053 |
$444K |
| 20610 |
|
3,586 |
3,218 |
$256K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
1,151 |
1,141 |
$189K |
| 96411 |
|
2,330 |
2,136 |
$131K |
| 96415 |
|
2,398 |
2,164 |
$98K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
4,489 |
4,094 |
$65K |
| 77080 |
|
1,426 |
1,422 |
$46K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
1,417 |
1,413 |
$27K |
| 20611 |
|
168 |
106 |
$17K |
| J1040 |
Injection, methylprednisolone acetate, 80 mg |
1,453 |
1,302 |
$12K |
| J1030 |
Injection, methylprednisolone acetate, 40 mg |
2,104 |
1,929 |
$10K |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
1,892 |
1,740 |
$8K |
| 96401 |
|
201 |
200 |
$8K |
| J1720 |
Injection, hydrocortisone sodium succinate, up to 100 mg |
366 |
327 |
$5K |
| 20605 |
|
87 |
84 |
$5K |
| J1010 |
Injection, methylprednisolone acetate, 1 mg |
418 |
367 |
$4K |
| 99406 |
|
163 |
149 |
$2K |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
2,300 |
2,104 |
$1K |
| J1020 |
Injection, methylprednisolone acetate, 20 mg |
246 |
238 |
$909.81 |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
12 |
12 |
$825.50 |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
166 |
164 |
$674.75 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
108 |
106 |
$584.85 |
| J0897 |
Injection, denosumab, 1 mg |
65 |
65 |
$463.01 |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
35 |
30 |
$167.41 |
| 99072 |
|
22 |
21 |
$15.00 |
| J1745 |
Injection, infliximab, excludes biosimilar, 10 mg |
41 |
40 |
$0.00 |